159 related articles for article (PubMed ID: 22563214)
1. Use of serum homocysteine to predict cardiovascular disease in Korean men with or without metabolic syndrome.
Kang JY; Park IK; Lee JY; Sung SH; Chang YK; Park YK; Choi TI
J Korean Med Sci; 2012 May; 27(5):500-5. PubMed ID: 22563214
[TBL] [Abstract][Full Text] [Related]
2. The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study.
Kim J; Pyo S; Yoon DW; Lee S; Lim JY; Heo JS; Lee S; Shin C
PLoS One; 2018; 13(10):e0206157. PubMed ID: 30352089
[TBL] [Abstract][Full Text] [Related]
3. Associations of Metabolic Syndrome with Total Testosterone and Homocysteine Levels in Male Korean Workers.
Sung SH; Kim NH; Hong SP; Lee JK; Choi SJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):158-168. PubMed ID: 31257744
[TBL] [Abstract][Full Text] [Related]
4. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine, vitamin B(6), and lipid in cardiovascular disease.
Chan SJ; Chang CN; Hsu JC; Lee YS; Shen CH
Nutrition; 2002; 18(7-8):595-8. PubMed ID: 12093437
[TBL] [Abstract][Full Text] [Related]
6. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and metabolic syndrome: from clustering to additional utility in prediction of coronary heart disease.
Esteghamati A; Hafezi-Nejad N; Zandieh A; Sheikhbahaei S; Ebadi M; Nakhjavani M
J Cardiol; 2014 Oct; 64(4):290-6. PubMed ID: 24631466
[TBL] [Abstract][Full Text] [Related]
8. Predictive cut-off values for the triglyceride-to-high-density lipoprotein cholesterol ratio to predict metabolic syndrome in the middle-aged Korean population.
Kim JY; Lee T; Chung TH
Nutr Metab Cardiovasc Dis; 2024 Apr; 34(4):882-892. PubMed ID: 38413357
[TBL] [Abstract][Full Text] [Related]
9. The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study.
Lee HS; In S; Park T
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371949
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria.
Gharipour M; Sadeghi M; Nezafati P; Dianatkhah M; Sarrafzadegan N
J Res Health Sci; 2019 May; 19(2):e00442. PubMed ID: 31278212
[TBL] [Abstract][Full Text] [Related]
11. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
Hwang IC; Kim KK; Jee SH; Kang HC
Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
[TBL] [Abstract][Full Text] [Related]
12. Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults.
Haghighatdoost F; Sarrafzadegan N; Mohammadifard N; Asgary S; Boshtam M; Azadbakht L
Nutrition; 2014 Jun; 30(6):636-44. PubMed ID: 24800666
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Carotid Plaque Contrast-Enhanced Ultrasound Score and Homocysteine in Senile Metabolic Syndrome Complicated by Cerebral Infarction.
Zuo Z; Xu Z; Cheng C; Yang S; Li M
J Coll Physicians Surg Pak; 2023 Oct; 33(10):1100-1105. PubMed ID: 37804013
[TBL] [Abstract][Full Text] [Related]
14. Association Between Leukocyte Telomere Length and Plasma Homocysteine in a Singapore Chinese Population.
Rane G; Koh WP; Kanchi MM; Wang R; Yuan JM; Wang X
Rejuvenation Res; 2015 Jun; 18(3):203-10. PubMed ID: 25546508
[TBL] [Abstract][Full Text] [Related]
15. The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease.
Cho NH; Kim JY; Kim SS; Shin C
Diabetes Metab Syndr; 2013; 7(4):226-32. PubMed ID: 24290090
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serum bilirubin levels and cardiovascular disease.
Suh S; Cho YR; Park MK; Kim DK; Cho NH; Lee MK
PLoS One; 2018; 13(2):e0193041. PubMed ID: 29447261
[TBL] [Abstract][Full Text] [Related]
17. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and cardiovascular diseases in Korea.
Suh S; Lee MK
J Atheroscler Thromb; 2014; 21 Suppl 1():S31-5. PubMed ID: 24452115
[TBL] [Abstract][Full Text] [Related]
19. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
[TBL] [Abstract][Full Text] [Related]
20. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
